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Circulating tumor cells (CTCs) and circulating clusters of cancer and stromal cells have been
identified in the blood of patients with malignant cancer and can be used as a diagnostic for
disease severity, assess the efficacy of different treatment strategies and possibly determine
the eventual location of metastatic invasions for possible treatment. There is thus a critical
need to isolate, propagate and characterize viable CTCs and clusters of cancer cells with
their associated stroma cells. Here, we present a microfluidic device for mL/min flow rate,
continuous-flow capture of viable CTCs from blood using deterministic lateral displacement
arrays. We show here that a deterministic bump array can be designed such that it will isolate
with efficiency greater than 85% CTCs over a large range in sizes from millimeter volume
clinical blood samples in minutes, with no effect on cell vitality so that further culturing and
analysis of the cells can be carried out.
Much of the recent work in this area has focused on capturing cells on epithelial antibody-
coated surfaces in microfluidic flow channels11,12, but these devices must be operated slowly (∼
mL/hr) to maintain capture efficiency and viable cell recover is difficult because cells are strongly
bound to the surface once they attach. Further, it is now clear that circulating clusters of cancer and
stromal cells (the latter forming the “seed and soil” hypothesis of metastasis 1–7, in principle single
patient analysis would aid in the development personalized treatments8,9. Because of the rarity
of CTCs (1-1000) cells/mL)3 compared to other cells in the blood and the large variation in their
morphology 10, large volumes have to be processed to deliver a sufficient number for statistical
detection and detailed characterization of the heterogeneity. CTCs (diameters 15 - 30 μm) are
on average larger than other cells in blood (2 - 15 μm)13, giving the possibility of enrichment
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with a size-based separation technique. Circulating clusters of cancer and stromal cells are even
larger, up to 200 μm in diameter 6. Several methods involving membrane based filtration14–16 or
devices relying on inertial effects17,18 have been developed to exploit this size difference. Both
of these approaches have yielded CTCs from blood with high capture efficiencies and enrichment
factors. However, because of the rarity of these cells (1-1000) cells/mL)3 compared to other cells
in the blood (red blood cells - 109 cells/mL, platelets - 108 cells/mL, and white blood cells - 106
cells/mL), large volumes of blood have to be processed to deliver a sufficient number for statistical
detection or study, and a large dynamic range of sizes must be accomodated ranging from single
cells to cell clusters. Because of the need for a large range of sizes, clogging may be an issue with
membrane-based technology, while the throughput of inertial techniques is limited by the heavy
dilutions that are necessary to maintain separation resolution.
Deterministic lateral displacement is a microfluidic size-based particle sorting method with
excellent size selectivity which does not depend on first order on the rate of flow since it does not
rely on diffusion, adaptability to sorting multiple particle sizes19 , and dynamic control of critical
particle sizes20. It has been demonstrated under a broad range of operating conditions, sorting
particles from 100 nm21 to 30 um22. In the method, an array of microposts direct particles above
a critical size at an angle with respect to the fluid flow direction so that the larger particles will
eventually become concentrated at one sidewall of the array. Using such an array, large particles
can be concentrated from an input stream and harvested at the end of the array by collecting the
output fluid stream separate from the rest of the fluid leaving the array. However, it has never been
demonstrated that a deterministic lateral displacement array can process the volumes needed for
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selection of rare circulating cells in whole blood in times of the order of minutes, and maintained
cell viability.
A unique aspect of the deterministic bump array present here is that triangular posts are
used rather than cyindical posts. Triangles provide for increased throughput and less clogging
compared to circular posts 23 microfluidic and Inglis’ wall design is used to ensure flow uniformity
near channel walls where particles are concentrated 24. Triangle posts offer a far greater range
of complexity in the motion of objects in a deterministic bump array because of the impact of
rotations of the posts in the array on the motion of objects in the array, as shown in Fig. 1 . The
ability of the device to direct the motion of particles is shown in the fluorescent trajectories of 3.1
μm polystyrene beads in an array with 12 μm gaps, 18 μm posts, 1/20 array tilt and 2.0 μm critical
size. Beads that are uniformly distributed at the array inlet are directed towards the central wall as
they travel through the array. At the outlet, nearly all of the beads are concentrated against the wall
and collected in the narrow collection output.
The layout of a concentrator device which allows this breakthrough in performance is shown
in Fig. 2 . It is composed of a 2.5 mm wide by 25 mm long flow chamber filled with a mirrored
array of 58 μm triangular posts with 42 μm gaps between posts. One axis of the array is tilted at
an angle of 1/20 radians with respect to the direction of fluid flow, which should give a critical size
of 7 microns. According the operating principles of DLD, large particles above a designed critical
size (e.g. the cancer cells) will flow along this tilted axis of the array, while the fluid and small
particles flow in the horizontal direction defined by the array sidewalls. The top section in the
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mirrored array directs large particles downward towards the central wall while the bottom section
directs them upward. This allows the device width to be doubled without increasing the array
length, which must typically be scaled with the array width as W/ to ensure all large particles are
displaced to the central wall. A fluid containing targeted particles is brought in from a single inlet
and flowed through the array. While traversing the array, large particles are concentrated towards
the center of the flow chamber and collected at a narrow collection output while all other fluid is
directed to a waste outlet. Devices are etched into a silicon wafer to a depth of 60 μm and sealed
with a PDMS-coated glass cover slide. Three devices are tiled in plane on each silicon layer and
external connections are made by mating an acrylic manifold to through-wafer holes etched into
device at inlet and outlet ports. The manifold is spring-loaded to withstand applied pressures up
to 4.7 atmospheres without leaking. Manifold, devices, and tubing are first wet with a running
buffer of 1x PBS, 1% BSA, and 1 mM EDTA. 5 mL of fluid was processed in each experiment at
various flow rates that were controlled by a syringe pump. The pressure drop across the device was
measured at 4 atmospheres at 10 mL/min flow rate for buffer and scaled linearly with flow rate.
Experiments were performed with approximately 107 cancer cells from breast or prostate cell
lines in 1 mL of growth medium spiked into buffer or blood diluted with buffer. Cells are cultured
using standard methods and used immediately after passage. Premalignant (MCF10A) and ma-
lignant (MDAMB231) epithelial breast cells contained a GFP or RFP construct that allowed them
to be easily differentiated from other non-fluorescent cells in solution. Device functionality with
cancer cells was confirmed by observing the trajectories of MDAMB231 breast cells expressing
GFP with epifluorescent microscopy at a flow rate of 100 μL/min (Fig. 3 ). Using cells in buffer,
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we can clearly see that cells enter the device broadly distributed from a single inlet as they enter
the array and are focused against the central wall and directed into the collection output at the end
of the array.
We confirmed the function of the DLD array at high flow rate by processing MCF10A breast
cells spiked in the wetting solution at 10 mL/min. 1 mL of growth medium with ∼ 107 cells
was diluted to 10 mL with the wetting solution and 5 mL of sample was processed in 30 s. Con-
centrations and size distribution of cells were measured for input, collection, and waste solutions
using a Coulter counter. From an initial concentration of 3.75 x 106cells/mL with average size
19.5μm, the collection output had a concentration of 2.1 x 107 cells/mL with average size 19.5μm
while waste output had a concentration of 3.7 x 105 cells/mL with average size 19.0 μm. Fac-
toring in the volume of each output (Vc = 0.8 mL, Vw = 4.2 mL), we can calculate the capture
efficiency as the ratio of cells in the collection output to the total number of cells in both outputs
# collected cells
total cells
= CcVc
CcVc+CwVw
. Using this definition, 91% of the targeted cells were collected by the
device.
Experiments were then performed with cancer cells spiked into blood to assess the potential
for separating CTCs from blood. Blood was supplied by donors from the Interstate Blood Bank
(Memphis, TN), shipped overnight and used within one day. Since blood has a higher viscosity
than water, a dilution between 5 and 20 times was performed to ensure that the device operated
below the pressure ceiling. In a first experiment, 500 μL of blood was added to 1 mL of growth
medium with ∼ 107 malignant MDAMB231 breast cells and then diluted to a total volume of 10
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mL with the wetting solution. 5 mL of this mixture was processed at 10 ml/min flow rate and
the output solutions were analyzed with a flow cytometer. MDAMB231 cells used expressed a red
fluorescent protein dTomato that was used to distinguish them from other cells in the mixture which
had no fluorescence. 50,000 total cells were analyzed from the input, collection output and waste
output. In each run and the number of large, fluorescent cells were enumerated from multivariable
analysis. 4.9% of the input cells were cancer cells, while 16.7% of collection output cells and
0.6% of waste output cells were cancer cells. If we assume that the concentrations of other cells
remain constant, we can normalize these percentages to the ratio of cancer cells to other cells in
each solution and get 0.05, 0.2 and 0.006 for input, collection and waste solutions respectively and
a capture efficiency in these conditions of 86%.
For 10 mL/min flow rate, the fluid velocities in the device range from near zero at the post
edges to ∼ 1.5 m/s in the middle of a gap between posts. This subjects the cells to an high shear
stress that might damage them. The strength of shear forces in a flow are characterized by a shear
rate defined as ∂vx/∂y, where x is the flow direction and y is the direction across a gap. The typical
range of shear rates in the body is 10 to 103 s−1 25. Cell viability was measured by application of
0.4%w Trypan blue in saline at a 10:1 dilution to input and output samples, vortexing, incubating
for 5 min at room temperature, and examining the resulting solution with a haemocytometer.
Passing through the DLD array had no effect on cell viability in several different cell lines
suspended in the running solution across a wide range of flow rates. In experiments, summarized
in Table 1 with three epithelial cell lines (MDAMB231, PC3, MCF10A) at various flow rates from
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0.1 to 10 mL/min, greater than 95% of the cells survived in each experiment. PC3 are malignant
prostate cancer cells. While the shear rates in these devices greatly surpasses physiological levels
(1-2000 s−1 26, we speculate that the reduced exposure time at the higher flow rates limits cellular
damage. At 10 mL/min, cells traverse the entire 25 mm array in about 70 ms. This observation
matches with observations of white blood cells in a rotary pump that suggest shear-induced damage
is an integral effect over time 27. That is, cell vitality decreases the longer cells are exposed to high
shear. Experiments done by Di Carlo et al.28 to examine gene expression in cells exposed to high
shear showed no significant changes. As a result, we do not expect shear-induced cell death or
alteration to be a significant limitation in the operation of these devices.
We further assessed cell vitality by culturing cells after they had passed through a device.
Approximately 106 MDAMB231 cells were spiked into whole blood diluted 10:1 and 5 mL of
this solution was driven through a single layer device at 5 mL/min. Red blood cells in the output
from the collection channel were lysed with 1x RBC lysis buffer (eBiosciences), washed with the
running solution and 500 μL of the resulting solution was placed into a 25 cm2 culture flask with 3
mL of growth media. Shown in Fig. 4 , the red fluorescent MDAMB231 cells attach to the surface
and proliferate. While there is a small background of white blood cells and unlysed red blood cells,
the cancer cells seem unaffected.
The 10 mL/min flow rates presented constitute a 50-fold improvement in flow rate over the
herringbone-CTC chip used by Stott et al.12, a 105-fold improvement over the 10s of μL/min his-
torical flow rates in DLD arrays 22,29 and a 100-fold improvement over more recent efforts by Inglis
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et al. 30 and are the fastest reported operation of these devices. With internal velocities exceeding
1 m/s and Reynolds number Re > 40, we confirm that the size-based separation functionality is
preserved even outside the low Reynolds number flow regime.
In summary, these experiments showed that high efficiency capture of cancer cells from
blood is possible at flow rates of 10 ml/m with no effect on cell vitality by using deterministic
lateral displacement arrays at flow rates much higher than used in previous microfluidic devices.
Operating devices in parallel could easily enable flow rates an order of magnitude larger, and de-
sign of more complex heterogenous triangle arrays will allow the separation of a vast range of
object sizes with no clogging issues. These results open up the possibility of rapid collection of
viable circulating tumor cells and clusters of cancer and stromal cells from the blood of patients
with metastatic disease. Capturing and propagating viable cells from patients could allow in vitro
chemotherapeutic treatments to be studied in vitro to determine which may be the most effective
in vivo and allow better study of the development of drug resistance.
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Flow Rate Cell Type Viability Cells Vmax Shear Rate Transit
(mL/min) Counted (cm/s) (s−1) Time (s)
0.1 MDAMB231 0.95 61 1.5 750 7.0
0.1 PC3 0.96 28 1.5 750 7.0
0.5 MCF10A 0.96 51 7.5 3750 1.4
5.0 MCF10A 1.00 123 75 37500 0.14
10.0 MCF10A 0.99 125 150 75000 0.07
Table 1: Viability Experiment Summary. Vmax defined as maximum velocity across a gap
extracted from numerical simulation, shear rate ∂vx/∂y estimated as maximum velocity in
the gap divided by half the 42 μm gap. Array length is 25 mm.
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Figure 1 Anisotropic Conduction Schematic of the movement of 3 different cells in
a deterministic lateral displacement array consisting of triangular posts. In a properly
designed array, cells below a lowest average hydrodynamic size, such as red blood cells
and white blood cells, simply follow the hydrodynamic streamlines. Cells above a critical
size, such as circulating tumor cells and circulating clumps, are pushed by the posts into
adjacent streamlines and move diagonally to the flow.
Figure 2 High Throughput Device. A concentrator deterministic lateral displacement
array with one input and two outputs (collection and waste) is used. Fluorescent micro-
graphs of the trajectories of 3.1 μm beads in arrays with 12 μm gaps, 18 μm triangular
posts, 1/20 array tilt and 2.0 μm critical size highlight device function. Using a mirrored
design, large particles dispersed in the inlet are focused against the central channel wall,
where they can be collected at the narrow collection output while other particles enter the
waste outlet.
Figure 3 CTC enrichment in DLD array. Trajectories of GFP-expressing MDAMB231
breast cells in an array with 42 μm gaps, 1/20 array tilt, and 7 μm critical particle size at
device inlet and outlet at flow rate of 500 μL/min. Cells are evenly dispersed at inlet but
are concentrated against central wall at outlet and directed to narrow collection outlet.
Figure 4 MDAMB231 cells are unaffected by passage through the DLD array. Time
series of cancer cells (red) spiked in blood shows proliferation in a culture flask after flow
through device at 5 mL/min flow rate.
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